2. Signaling Pathways
  3. NF-κB
  4. NF-κB
  5. NF-κB Antagonist

NF-κB Antagonist

NF-κB Isoform Comparison

NF-κB Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-156850
    ITF 3756
    		Antagonist 98.55%
    ITF 3756 is a selective, orally active HDAC6 inhibitor. ITF 3756 antagonizes TNF-α-induced activation of the NF-κB pathway. ITF 3756 reduces PD-L1 expression on human monocytes and CD8+ T cells, and exhibits antitumor activity. ITF 3756 can be used in colon cancer-related research.